WE ARE
A pharmaceutical company specialized in high quality
ONCOLOGY PRODUCTS
We are a pharmaceutical company specialized in high-quality oncology products in the Middle East. Actero is the result of the joint venture between Actoverco (the Iranian leading pharmaceutical company) and a renowned multinational company currently present in 120 countries.
We are building a unique range of products to cover the needs of cancer patients. Actero is not only focused on chemotherapy, but understands cancer treatment as a whole. That is why we invest in high-quality oncology drugs, as well as in palliative care. All across our portfolio, every Actero medicine stands for reliability.
July 24, 2022
Actero Support in Congress 1400
Actero company’s social respomsibility of patient support in Hematology-Oncology Congress and Radiation Therapy Congress
/
November 16, 2021
Best of ASCO 2021
The aforesaid seminar has been held for the first time in Iran with the hospitality of Isfahan city, with the cooperation of Radiation-Oncologists from all over of the country and Actero Pharma.
/
November 16, 2021
“Uro-Oncology Tumor board: Challenges of Prostate Cancer Treatment” (Semi-Virtual)
Uro-Oncology research Center of Tehran University of Medical science, in cooperation with Actero Pharma has held a semi-virtual tumor board.
/
Find Your Product
With our products, we contribute to the health of people and plants. Here you find an overview of the major Acteropharma products.
A
Z
We understand that pharmaceutical industry is not comparable to other industries. That is why ethical behavior is at the heart of our business.